Explore Stanford technologies available for licensing:

S25-139
An Integrin-Targeting Peptide for Enhanced Lysosomal Delivery of Antibody-Drug Conjugates

Stanford researchers have developed a modular bioconjugation platform that improves the potency and selectivity of antibody-drug conjugates (ADCs) by enhancing their lysosomal internalization.

Collections

Life Sciences

Life Sciences

Our Life Sciences collection features technologies in the fields of neuromodulation, immuno-oncology, digital health, and more.
Physical Sciences

Physical Sciences

Our Physical Sciences technology collection features battery technologies, solar cells, quantum computing, and more.
Sustainability

Sustainability

Our Sustainability technology collection features battery, photovoltaic, water treatment, and agricultural technologies.
Artificial Intelligence

Artificial Intelligence

Our Artificial Intelligence technology collection features innovations in machine learning, natural language processing, computer vision, generative AI, and more.